Blueprint Medicines and CStone Pharmaceuticals Announce Exclusive Collaboration and License Agreement Read more
Chimerix Receives Orphan Drug Designation from the FDA for Brincidofovir for the Treatment of Smallpox Read more
Ironwood Pharmaceuticals Announces FDA Orphan Drug Designation for Olinciguat for the Treatment of Sickle Cell Disease Read more
BlackThorn Therapeutics Initiates Phase 1 Study of BTRX-335140, an Investigational Kappa Opioid Receptor (KOR) Antagonist Read more
Chugai’s HEMLIBRA Receives Priority Review Status from FDA for Hemophilia A Without Inhibitors Read more
Hookipa and Gilead Enter into a Collaboration and License Agreement to Develop Immunotherapies Against HIV and Hepatitis B Read more